TABLE 2.

Association between IgE antibodies and clinical aspects of CL

Presence of antileishmanial IgE antibodiesNo. of patients/total (%)Result (mm), mean ± SD
Cure at day 90Presence of one lesionLesion sizeSkin test
Positive5/18 (28)15/18 (83)a18 ± 5.418 ± 12.2b
Negative10/26 (38)14/27 (52)17 ± 7.99 ± 6.9
  • a χ20.05 significant level.

  • b Mann-Whitney U test significant level (0.05).